SCHEMBL5559345

SCHEMBL5559345

OCc1coc(-c2nn(-c3ccccc3)c3ccccc23)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.55
ALDH1A1 P00352 4/20 0.37
CYP1A2 P05177 3/20 0.37
CYP2D6 P10635 3/20 0.37
KDM4E B2RXH2 3/20 0.37
MAPT P10636 3/20 0.37
CYP3A4 P08684 2/20 0.37
NPC1 O15118 2/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MAPK1 P28482 2/20 0.37
GMNN O75496 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX15 P16050 1/20 0.37
NFKB1 P19838 1/20 0.37
CYP2C19 P33261 1/20 0.37
RAB9A P51151 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5558869 0.82 CYP2D6 (0.57) PDE5AALDH1A1CYP1A2CYP2D6KDM4E
SCHEMBL5563515 0.77 PDE5A (0.55) PDE5AALDH1A1CYP1A2CYP2D6KDM4E
SCHEMBL5562974 0.75 PDE5A (0.63) PDE5AALDH1A1CYP1A2CYP2D6KDM4E
SCHEMBL5564729 0.74 PDE5A (0.55) PDE5AALDH1A1CYP1A2CYP2D6KDM4E
SCHEMBL5558478 0.74 PDE5A (0.62) PDE5AALDH1A1CYP1A2CYP2D6KDM4E
SCHEMBL5558976 0.74 PDE5A (0.65) PDE5AALDH1A1CYP1A2CYP2D6KDM4E
SCHEMBL5563642 0.74 PDE5A (0.52) PDE5AALDH1A1KDM4EMAPTNPC1
SCHEMBL5565325 0.71 PDE5A (0.57) PDE5AALDH1A1CYP1A2CYP2D6KDM4E
SCHEMBL5563961 0.71 PDE5A (1.00) PDE5AALDH1A1CYP1A2CYP2D6KDM4E
SCHEMBL13865174 0.70 CYP2D6 (0.56) PDE5AALDH1A1CYP1A2CYP2D6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646382-A2 COMPOUNDS, COMPOSITIONS AND METHODS HIF BIO INC. (US) 2006-04-19 EP claimed
US-20050187276-A1 Compounds, compositions and methods BIZBIOTECH CO., LTD. (KR) 2005-08-25 US claimed
WO-2005030121-A2 COMPOUNDS, COMPOSITIONS AND METHODS HIF BIO, INC. (US) 2005-04-07 WO claimed
US-7226941-B2 Compound for treating angiogenesis HIF BIO, INC. (US) 2007-06-05 US disclosed
US-20050187276-A1 Compounds, compositions and methods BIZBIOTECH CO., LTD. (KR) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187276-A1 Compounds, compositions and methods HIF1A, HIF1AN, EGLN3 PDE5A 1987/4885ALDH1A1 858/4885CYP1A2 2118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.